| ACWIX | VSGAX | ACWIX / VSGAX | |
| Total Expense Ratio | 0.87 | 0.07 | 1,243% |
| Annual Report Gross Expense Ratio | 1.13 | 0.07 | 1,614% |
| Fund Existence | 15 years | 15 years | - |
| Gain YTD | 17.088 | 17.371 | 98% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 3000 | 3,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 44M | 47B | 0% |
| Annual Yield % from dividends | 0.00 | 0.41 | - |
| Returns for 1 year | 17.87 | 26.87 | 66% |
| Returns for 3 years | 37.57 | 51.26 | 73% |
| Returns for 5 years | 27.00 | 27.71 | 97% |
| Returns for 10 years | 63.05 | 181.60 | 35% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| KMKAX | 81.91 | N/A | N/A |
| Kinetics Market Opportunities Adv A | |||
| LCBVX | 43.64 | N/A | N/A |
| ClearBridge Large Cap Value R | |||
| LICTX | 21.26 | N/A | N/A |
| Lord Abbett International Equity R5 | |||
| BKMIX | 10.69 | N/A | N/A |
| BlackRock Multi-Asset Income Portfolio K | |||
| LYFIX | 18.74 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare I | |||